Thalys Medical Technology Group, Inc. engages in the research, development, production and sale of in vitro diagnostic products. The company also involves in the provision of medical testing marketing services. Its products include automatic coagulation analyzers, coagulation reagents, automatic fluorescence immunoassay analyzers, blood gas detection analyzers and biochemical analysis systems. The company was founded on February 23, 2004 and is headquartered in Wuhan, China.